Venture Investors Health Limited Partnership — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Cellectar BiosciencesNASDAQ: CLRBSep 2023SEC filingmedium confidence
BiotechMadison, US
Frederick W. Driscoll(Director)John E. Friend II(Executive Officer)Douglas J. Swirsky(Director)Stefan Loren(Director)Stephen A. Hill(Director)James V. Caruso(Executive Officer, Director)
Board seatJohn Neis· per SEC Form D · $24.5M raise · filed Sep 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.